Pharma Stocks
-
Lexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative
Lexicon Pharmaceuticals (LXRX) recently completed patient randomization in its pivotal Phase 3 SONATA HCM trial of sotagliflozin for obstructive and…
Read More » -
How Investors Are Reacting To Supernus Pharmaceuticals (SUPN) Positive Earnings ESP And Renewed Beat Expectations
In the lead-up to its early August 2026 earnings release, Supernus Pharmaceuticals attracted attention after analysts highlighted its positive Earnings…
Read More » -
Are Ananda Pharma (LSE:ANA) And Celadon Pharmaceuticals (LSE:CEL) Keeping UK Cannabis Stocks On Watch?
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks The end of the…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 30, 2026)
Zealand Pharma Company announcement No. 35 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 30, 2026)…
Read More » -
London Stocks Gain as US-Iran Pause & Earnings Boost Market Sentiment
London Stocks Climb as US-Iran Pause and Earnings Spur Investor Optimism FTSE Indices React to Geopolitical Tensions and Earnings Reports…
Read More » -
Roche stock trades steadily as diagnostics and pharma revenue support valuation
Roche Holding AG (ISIN CH0012032048) remains a core name in global healthcare, with Roche stock representing a diversified exposure to…
Read More » -
Teva’s Turnaround Is Working. Here’s the 1 Thing That Could Send It Soaring Another 50%.
Year to date, Teva Pharmaceutical Industries (NYSE: TEVA) shares have continued to recover. Thanks to the company’s shifting focus from…
Read More » -
CSPC Pharmaceutical Group (SEHK:1093) Could Be 115% Below Fair Value Following Drug Approval
CSPC Pharmaceutical Group (SEHK:1093) has secured marketing approval in China for its once-monthly Paliperidone Palmitate Injection for schizophrenia, a development…
Read More » -
Israel “Izzy” Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn’t?
You don’t become one of the world’s wealthiest hedge fund managers by making ill-advised investing decisions. And make no mistake…
Read More »